o.pereira
Submits third-party assay reports on material purchased directly. Based in Accra.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
98.74%
n=6
Suppliers covered
4
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043404 | Semaglutide | WXT | WXT-2604-C4728 | Janoshik | 2026-Q3 | 96.37 | 4.07 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-041583 | CJC-1295 (no DAC) | QSC | QSC-2601-B7339 | PeptideMeter | 2026-Q2 | 98.81 | 5.36 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041878 | Thymulin | JEEP | JEEP-2602-T3807 | PeptideMeter | 2026-Q1 | 99.14 | 5.25 | 95.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018772 | Survodutide | QSC | QSC-2506-B8101 | Janoshik | 2025-Q4 | 98.67 | 6.31 | 105.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018891 | Semaglutide | QSC | QSC-2503-U9441 | Janoshik | 2025-Q2 | 98.93 | 7.13 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005524 | Semaglutide | BCH | BCH-2401-C7932 | Janoshik | 2024-Q2 | 98.09 | 6.25 | 92.5 | Supplier-supplied | 2 | MARGINAL |